Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors (CNTO95/Avastin)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00888043
Recruitment Status : Completed
First Posted : April 24, 2009
Last Update Posted : March 11, 2015
Centocor, Inc.
Genentech, Inc.
Information provided by (Responsible Party):
Herbert Hurwitz, MD, Duke University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : January 2015